Singapore, July 3 -- FUJIFILM Corporation partners with Dr. Reddy's Laboratories Ltd., a global pharmaceutical company headquartered in India and Global Response Aid, a global provider of medical supplies and pharmaceuticals, aimed at overseas deployment of a treatment drug for COVID-19.

On June 30, a Tripartite Licensing Agreement was concluded between FUJIFILM Toyama Chemical Co., Ltd., Dr. Reddy's, and GRA, concerning the development, manufacture and sales of Avigan(R) Tablets (generic name: favipiravir), which is a potential drug for a treatment of COVID-19. Under the Agreement, FUJIFILM Toyama Chemical will grant Dr. Reddy's and GRA the exclusive right to develop, manufacture*1 and sell Avigan overseas*2, and, receive a lump-sum lic...